Loss of PICH Results in Chromosomal Instability, p53 Activation, and Embryonic Lethality
Eliene Albers,
Mauro Sbroggiò,
David Pladevall-Morera,
Anna H. Bizard,
Alexandra Avram,
Patricia Gonzalez,
Javier Martin-Gonzalez,
Ian D. Hickson,
Andres J. Lopez-Contreras
Affiliations
Eliene Albers
Department of Cellular and Molecular Medicine, Center for Chromosome Stability and Center for Healthy Aging, University of Copenhagen, Copenhagen 2200, Denmark
Mauro Sbroggiò
Department of Cellular and Molecular Medicine, Center for Chromosome Stability and Center for Healthy Aging, University of Copenhagen, Copenhagen 2200, Denmark
David Pladevall-Morera
Department of Cellular and Molecular Medicine, Center for Chromosome Stability and Center for Healthy Aging, University of Copenhagen, Copenhagen 2200, Denmark
Anna H. Bizard
Department of Cellular and Molecular Medicine, Center for Chromosome Stability and Center for Healthy Aging, University of Copenhagen, Copenhagen 2200, Denmark
Alexandra Avram
Department of Cellular and Molecular Medicine, Center for Chromosome Stability and Center for Healthy Aging, University of Copenhagen, Copenhagen 2200, Denmark
Patricia Gonzalez
Histopathology Core Unit, Spanish National Cancer Research Centre, Madrid 28029, Spain
Javier Martin-Gonzalez
Transgenic Core Facility, Department of Experimental Medicine, University of Copenhagen, Copenhagen 2200, Denmark
Ian D. Hickson
Department of Cellular and Molecular Medicine, Center for Chromosome Stability and Center for Healthy Aging, University of Copenhagen, Copenhagen 2200, Denmark
Andres J. Lopez-Contreras
Department of Cellular and Molecular Medicine, Center for Chromosome Stability and Center for Healthy Aging, University of Copenhagen, Copenhagen 2200, Denmark; Corresponding author
Summary: PICH is a DNA translocase necessary for the resolution of ultrafine anaphase DNA bridges and to ensure the fidelity of chromosomal segregation. Here, we report the generation of an animal model deficient for PICH that allowed us to investigate its physiological relevance. Pich KO mice lose viability during embryonic development due to a global accumulation of DNA damage. However, despite the presence of chromosomal instability, extensive p53 activation, and increased apoptosis throughout the embryo, Pich KO embryos survive until day 12.5 of embryonic development. The absence of p53 failed to improve the viability of the Pich KO embryos, suggesting that the observed developmental defects are not solely due to p53-induced apoptosis. Moreover, Pich-deficient mouse embryonic fibroblasts exhibit chromosomal instability and are resistant to RASV12/E1A-induced transformation. Overall, our data indicate that PICH is essential to preserve chromosomal integrity in rapidly proliferating cells and is therefore critical during embryonic development and tumorigenesis. : Albers et al. show that PICH is essential for mouse embryonic development and that PICH deficiency limits oncogenic-induced cellular transformation. These findings suggest that PICH activity is critical during events requiring rapid cell proliferation such as embryonic development and tumorigenesis. Keywords: Pich, Ercc6l, ultrafine anaphase DNA bridges, UFBs, genomic instability, DNA damage, X chromosome inactivation